Small cell lung cancer clinical trials

Small cell lung cancer (SCLC) accounts for 10% to 15% of all  lung cancer cases.¹

SCLC is a less common form of lung cancer.

SCLC can be challenging because it grows faster than other types of lung cancer and is usually not detected until it has spread to other parts of the body (metastasizes). Our goal is to discover new options that may treat SCLC.

There is a lot to consider when deciding whether to participate in a clinical trial. Any clinical trial includes risks, which the study doctor will review with you. Make sure you understand the risks before participating.

A woman speaking to a female doctor while walking down a hall.

Female doctor listening to an older man's heart while a younger woman watches.

Resources for patients

For help understanding clinical trial listings and for other resources, visit our Patient Resources section.

Browse resources

Senior female patient in discussion with doctor during check up in exam room

About clinical trials

Learn what clinical trials are, how they work, and if you may be eligible to participate.

Learn more

Reference:
1. What Is Lung Cancer. American Cancer Society. Updated January 29, 2024. Accessed August 24, 2026. https://www.cancer.org/cancer/types/lung-cancer/about/what-is.html